# First draft genome sequence of Candidozyma auris from a human clinical isolate in a major metropolitan hospital in Lima, Peru

## TL;DR

This paper provides the first draft genome of a fluconazole-resistant Candidozyma auris isolate from a patient in Lima, Peru.

## Contribution

The study presents the first genome sequence of C. auris from Peru, highlighting its antifungal resistance.

## Key findings

- A fluconazole-resistant Candidozyma auris isolate was obtained from a clinical sample in Lima, Peru.
- The draft genome sequence is reported for this emerging pathogenic yeast.

## Abstract

We present the draft genome sequence of a fluconazole-resistant Candidozyma auris isolate obtained from a Peruvian referral hospital. C. auris is an emerging pathogenic yeast of significant public health concern due to its antifungal resistance, particularly in patients with comorbidities.